הכנסה תפעולית לפני ניכוי פחת: prophaselabs.com (PRPH)
The EBITDA indicator on GURU.Markets illustrates business liquidity dynamics, where the value of 0.00 expresses the metric level. ProPhase Labs, Inc. (PRPH) is scaling the implementation of Nebula NGS tests and LineaRx diagnostics, expanding its B2B network in the US. High margins in genomics offset low pricing power in mass testing, helping the company successfully pivot from saturated markets toward early cancer detection.
פילוחי נתונים אנליטיים מרוכזים עבור ProPhase Labs (PRPH)
Absolute operating profit measures the daily liquidity inflow from core activities, allowing for an assessment of the business's real cash efficiency prior to reporting adjustments. For ProPhase Labs, Inc. (PRPH), this metric reflects the monetization of AI platforms in cancer diagnostics, and an analysis of EBITDA chronology helps determine whether operating cash flow offsets R&D expenses to ensure capital sustainability.
